Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 1, 2007, Pages 54-58

  Ohtake, Akiyoshi ^a   Saitoh, Chikashi ^a   Yuyama, Hironori ^a   Ukai, Masashi ^a   Okutsu, Hiroko ^a   Noguchi, Yukiko ^a   Hatanaka, Toshiki ^a   Suzuki, Masanori ^a   Sato, Shuichi ^a   Sasamata, Masao ^a   Miyata, Keiji ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Bladder capacity; Muscarinic receptor; Solifenacin; Urinary bladder

Indexed keywords

ATROPINE; CARBACHOL; DARIFENACIN; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PROPIVERINE; SOLIFENACIN; TOLTERODINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BLADDER CONTRACTION; BLADDER PRESSURE; CONTROLLED STUDY; CYSTOMETRY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG POTENCY; DRUG RECEPTOR BINDING; MALE; NONHUMAN; OVERACTIVE BLADDER; RAT;

ANIMALS; ATROPINE; BENZHYDRYL COMPOUNDS; BENZILATES; BENZOFURANS; BINDING, COMPETITIVE; CARBACHOL; CHO CELLS; CHOLINERGIC AGONISTS; CRESOLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MANDELIC ACIDS; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; N-METHYLSCOPOLAMINE; PHENYLPROPANOLAMINE; PYRROLIDINES; QUINUCLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, MUSCARINIC; TETRAHYDROISOQUINOLINES; TRANSFECTION; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URINATION;

EID: 33846111704     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.54     Document Type: Article

References (28)

1. Caulfield M. P., Birdsall N. J., Pharmacol. Rev., 50, 279-290 (1998).
2. Wang P., Luthin G. R., Ruggieri M. R., J. Pharmacol. Exp. Ther., 273, 959-966 (1995).
3. Longhurst P. A., Leggett R. E., Briscoe J. A., Br. J. Pharmacol., 116, 2279-2285 (1995).
4. Hegde S. S., Choppin A., Bonhaus D., Briaud S., Loeb M., Moy T. M., Loury D., Eglen R. M., Br. J. Pharmacol., 120, 1409-1418 (1997).
5. Matsui M., Motomura D., Karasawa H., Fujikawa T., Jiang J., Komiya Y., Takahashi S., Taketo M. M., Proc. Natl. Acad. Sci. U.S.A., 97, 9579-9584 (2000).
6. Moore K. H., Hay D. M., Imrie A. E., Watson A., Goldstein M., Br. J. Urol., 66, 479-485 (1990).
7. Thuroff J. W., Bunke B., Ebner A., Faber P., de Greeter P., Hannappel J., Heidler H., Madersbacher H., Melchior H., Schafer W., Schwenzer T., Stockle M., J. Urol., 145, 813-817 (1991).
8. Chapple C. R., Yamanishi T., Chess-Williams R., Urology, 60, 82-89 (2002).
9. Ikeda K., Kobayashi S., Suzuki M., Miyata K., Takeuchi M., Yamada T., Honda K., Naunyn-Schmiedebergs Arch. Pharmacol., 366, 97-103 (2002).
10. Lazareno S., Birdsall N. J., Br. J. Pharmacol., 109, 1110-1119 (1993).
11. Arunlakshana O., Schild H. O., Br. J. Pharmacol., 14, 48-58 (1959).
12. Moriya H., Takagi Y., Nakanishi T., Hayashi M., Tani T., Hirotsu I., Life Sci., 64, 2351-2358 (1999).
13. Nilvebrant L., Andersson K.-E., Gillberg P. G., Stahl M., Sparf B., Eur. J. Pharmacol., 327, 195-207 (1997).
14. Kenakin T. P., Pharmacol. Rev., 36, 165-222 (1984).
15. Tokuno H., Chowdhury J. U., Tomita T., Naunyn Schmiedebergs Arch. Pharmacol., 348, 659-662 (1993).
16. Suzuki M., Ohtake A., Yoshino T., Yuyama H., Hayashi A., Ukai M., Okutsu H., Noguchi Y., Sato S., Sasamata M., Eur. J. Pharmacol., 512, 61-66 (2005).
17. Maggi C. A., Conte B., J. Auton. Nervous System., 30, 247-251 (1990).
18. Ohtake A., Ukai M., Hatanaka T., Kobayashi S., Ikeda K., Sato S., Miyata K., Sasamata M., Eur. J. Pharmacol., 492, 243-250 (2004).
19. Kobayashi S., Ikeda K., Miyata K., Life Sci., 74, 843-853 (2004).
20. Ishikawa Y., Eguchi T., Skowronski M. T., Ishida H., Biochem. Biophys. Res. Commun., 245, 835-840 (1998).
21. Meloy T. D., Daniels D. V., Hegde S. S., Eglen R. M., Ford A. P. D. W., Br. J. Pharmacol., 132, 1606-1614 (2001).
22. Takeuchi J., Fulton J., Jia Z., Abramov-Newerly W., Jamot L., Sud M., Coward D., Ralph M., Roder J., Yeomans J., Pharmacol. Biochem. Behav., 72, 117-123 (2002).
23. Gautam D., Heard T. S., Cui Y., Miller G., Bloodworth L., Wess J., Mol. Pharmacol., 66, 260-267 (2004).
24. Nakamura T., Matsui M., Uchida K., Futatsugi A., Kusakawa S., Matsumoto N., Nakamura K., Manabe T., Taketo M. M., Mikoshiba K., J. Physiol., 558, 561-575 (2004).
25. Chapple C. R., Arano P., Bosch J. L. H. R., De Ridder D., Kramer G., Ridder A. E. J. L., B.J.U. Int., 93, 71-77 (2004).
26. Chapple C. R., Rechberger T., Al-Shukri S., Meffan P., Everaert K., Huang M., Ridder A., B.J.U. Int., 93, 303-310 (2004).
27. Haab F., Cardozo L., Chapple C., Ridder A. M., Eur. Urol., 47, 376-384 (2005).
28. Chapple C. R., Martinez-Garcia R., Selvaggi L., Toozs-Hobson P., Warnack W., Drogendijk T., Wright D. M., Bolodeoku J., Eur. Urol., 48, 464-470 (2005).